•
Mar 31, 2024

Selecta Biosciences Q2 2024 Earnings Report

Total Revenue
$5.84M
Previous year: $5.25M
+11.3%
EPS
$0.54
Previous year: -$0.07
-871.4%
Gross Profit
$5.66M
Previous year: $11.2M
-49.4%
Cash and Equivalents
$103M
Previous year: $112M
-7.7%
Free Cash Flow
-$16.5M
Previous year: -$9.91M
+66.7%
Total Assets
$325M
Previous year: $140M
+133.1%

Selecta Biosciences

Selecta Biosciences